{"id":"https://openalex.org/W2585794098","doi":"https://doi.org/10.1001/jamaoncol.2016.6435","title":"Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia","display_name":"Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia","publication_year":2017,"publication_date":"2017-02-02","ids":{"openalex":"https://openalex.org/W2585794098","doi":"https://doi.org/10.1001/jamaoncol.2016.6435","mag":"2585794098","pmid":"https://pubmed.ncbi.nlm.nih.gov/28152123","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5547922"},"language":"en","primary_location":{"id":"doi:10.1001/jamaoncol.2016.6435","doi":"https://doi.org/10.1001/jamaoncol.2016.6435","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jamaoncol.2016.6435","pdf_url":null,"source":{"id":"https://openalex.org/S2756165422","display_name":"JAMA Oncology","issn_l":"2374-2437","issn":["2374-2437","2374-2445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/pmc/articles/PMC5547922","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082365813","display_name":"Natalie M. Ertz-Archambault","orcid":"https://orcid.org/0000-0001-6034-7119","observed_orcids":["https://orcid.org/0000-0001-6034-7119"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210127938","display_name":"Mayo Clinic Hospital","ror":"https://ror.org/03660jn93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4210127938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Natalie Ertz-Archambault","raw_affiliation_strings":["Department of Internal Medicine, Mayo Clinic, Phoenix, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Mayo Clinic, Phoenix, Arizona","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210127938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038693643","display_name":"Heidi Kosiorek","orcid":"https://orcid.org/0000-0002-4651-9516","observed_orcids":["https://orcid.org/0000-0002-4651-9516"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heidi Kosiorek","raw_affiliation_strings":["Division of Health Sciences Research, Section of Biostatistics, Mayo Clinic, Phoenix, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Health Sciences Research, Section of Biostatistics, Mayo Clinic, Phoenix, Arizona","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030463388","display_name":"Gretchen Taylor","orcid":"https://orcid.org/0000-0002-7680-6428","observed_orcids":["https://orcid.org/0000-0002-7680-6428"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210127938","display_name":"Mayo Clinic Hospital","ror":"https://ror.org/03660jn93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4210127938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gretchen E. Taylor","raw_affiliation_strings":["Department of Internal Medicine, Mayo Clinic, Phoenix, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Mayo Clinic, Phoenix, Arizona","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210127938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110550682","display_name":"Katalin Kelemen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210127938","display_name":"Mayo Clinic Hospital","ror":"https://ror.org/03660jn93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4210127938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katalin Kelemen","raw_affiliation_strings":["Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, Arizona","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210127938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090009905","display_name":"Amylou Constance Dueck","orcid":"https://orcid.org/0000-0002-9912-1085","observed_orcids":["https://orcid.org/0000-0002-9912-1085"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amylou Dueck","raw_affiliation_strings":["Division of Health Sciences Research, Section of Biostatistics, Mayo Clinic, Phoenix, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Health Sciences Research, Section of Biostatistics, Mayo Clinic, Phoenix, Arizona","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085167360","display_name":"Janna C. Castro","orcid":"https://orcid.org/0000-0003-2628-2942","observed_orcids":["https://orcid.org/0000-0003-2628-2942"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janna Castro","raw_affiliation_strings":["Department of Information Technology, Mayo Clinic, Phoenix, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Information Technology, Mayo Clinic, Phoenix, Arizona","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Robert Marino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Marino","raw_affiliation_strings":["Division of Planning and Practice Analysis, Mayo Clinic, Phoenix, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Planning and Practice Analysis, Mayo Clinic, Phoenix, Arizona","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001494864","display_name":"Susanne M. Gauthier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susanne Gauthier","raw_affiliation_strings":["Division of Planning and Practice Analysis, Mayo Clinic, Phoenix, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Planning and Practice Analysis, Mayo Clinic, Phoenix, Arizona","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023290487","display_name":"Laura Elizabeth Finn","orcid":"https://orcid.org/0000-0002-4980-8997","observed_orcids":["https://orcid.org/0000-0002-4980-8997"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Finn","raw_affiliation_strings":["Department of Hematology and Oncology, Mayo Clinic, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Mayo Clinic, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111293822","display_name":"Lisa Z. Sproat","orcid":"https://orcid.org/0000-0002-6419-7581","observed_orcids":["https://orcid.org/0000-0002-6419-7581"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210127938","display_name":"Mayo Clinic Hospital","ror":"https://ror.org/03660jn93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4210127938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa Z. Sproat","raw_affiliation_strings":["Department of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210127938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057941081","display_name":"Jeanne M. Palmer","orcid":"https://orcid.org/0000-0002-2185-1504","observed_orcids":["https://orcid.org/0000-0002-2185-1504"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210127938","display_name":"Mayo Clinic Hospital","ror":"https://ror.org/03660jn93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4210127938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeanne Palmer","raw_affiliation_strings":["Department of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210127938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039057642","display_name":"Ruben A. Mesa","orcid":"https://orcid.org/0000-0001-5880-7972","observed_orcids":["https://orcid.org/0000-0001-5880-7972"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210127938","display_name":"Mayo Clinic Hospital","ror":"https://ror.org/03660jn93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4210127938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruben A. Mesa","raw_affiliation_strings":["Department of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210127938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008422091","display_name":"Aref Al\u2010Kali","orcid":"https://orcid.org/0000-0002-0824-3715","observed_orcids":["https://orcid.org/0000-0002-0824-3715"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aref Al-Kali","raw_affiliation_strings":["Department of Hematology and Oncology, Mayo Clinic, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Mayo Clinic, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035051206","display_name":"James M. Foran","orcid":"https://orcid.org/0000-0003-1673-1708","observed_orcids":["https://orcid.org/0000-0003-1673-1708"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Foran","raw_affiliation_strings":["Department of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida","institution_ids":["https://openalex.org/I4210146710"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018041025","display_name":"Raoul Tibes","orcid":"https://orcid.org/0000-0002-1372-8733","observed_orcids":["https://orcid.org/0000-0002-1372-8733"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210127938","display_name":"Mayo Clinic Hospital","ror":"https://ror.org/03660jn93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4210127938"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Raoul Tibes","raw_affiliation_strings":["Department of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210127938"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5018041025"],"corresponding_institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210127938"],"apc_list":null,"apc_paid":null,"fwci":11.1493,"has_fulltext":false,"cited_by_count":114,"citation_normalized_percentile":{"value":0.98944772,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"3","issue":"7","first_page":"936","last_page":"936"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.8672000169754028,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.8672000169754028,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14078","display_name":"Multiple and Secondary Primary Cancers","score":0.047600001096725464,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.02329999953508377,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/therapy-related-myeloid-neoplasms","display_name":"therapy-related myeloid neoplasms","score":0.925000011920929},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9259999990463257},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/autoimmune-disease","display_name":"autoimmune disease","score":0.9020000100135803},{"id":"https://openalex.org/keywords/cytotoxic-drugs","display_name":"cytotoxic drugs","score":0.7099999785423279},{"id":"https://openalex.org/keywords/immunomodulating-agents","display_name":"immunomodulating agents","score":0.9549999833106995},{"id":"https://openalex.org/keywords/azathioprine","display_name":"azathioprine","score":0.9559999704360962},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.6729999780654907},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.7039999961853027},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.6909999847412109},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.9309999942779541},{"id":"https://openalex.org/keywords/systemic-lupus-erythematosus","display_name":"systemic lupus erythematosus","score":0.9990000128746033}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9669933915138245},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.7285522222518921},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.7284718751907349},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4636562764644623},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.44971123337745667},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4343656897544861},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34273695945739746},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28512969613075256},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.07028117775917053}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001379","descriptor_name":"Azathioprine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008180","descriptor_name":"Lupus Erythematosus, Systemic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008942","descriptor_name":"Mitoxantrone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009173","descriptor_name":"Mycophenolic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D015122","descriptor_name":"Mercaptopurine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016017","descriptor_name":"Odds Ratio","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016022","descriptor_name":"Case-Control Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1001/jamaoncol.2016.6435","doi":"https://doi.org/10.1001/jamaoncol.2016.6435","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jamaoncol.2016.6435","pdf_url":null,"source":{"id":"https://openalex.org/S2756165422","display_name":"JAMA Oncology","issn_l":"2374-2437","issn":["2374-2437","2374-2445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Oncology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4993629","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC5547922","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5547922","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5547922","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Oncol","raw_type":"Text"},{"id":"pmid:28152123","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28152123","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA oncology","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:4993629","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC5547922","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G9000866180","display_name":"Mayo Clinic Comprehensive Cancer Center Support Grant","funder_award_id":"P30CA015083","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W13802598","https://openalex.org/W574684262","https://openalex.org/W1513711973","https://openalex.org/W1577140836","https://openalex.org/W1600262245","https://openalex.org/W1605230984","https://openalex.org/W1795206698","https://openalex.org/W1842574050","https://openalex.org/W1867014089","https://openalex.org/W1976422788","https://openalex.org/W1979300931","https://openalex.org/W1980141536","https://openalex.org/W1998941535","https://openalex.org/W2025400985","https://openalex.org/W2036281060","https://openalex.org/W2050182784","https://openalex.org/W2053953221","https://openalex.org/W2057266344","https://openalex.org/W2075877031","https://openalex.org/W2082431379","https://openalex.org/W2116096217","https://openalex.org/W2117015521","https://openalex.org/W2120850031","https://openalex.org/W2125657144","https://openalex.org/W2129049052","https://openalex.org/W2135647037","https://openalex.org/W2158006783","https://openalex.org/W2159728707","https://openalex.org/W2168286467","https://openalex.org/W2171021842","https://openalex.org/W2264982566","https://openalex.org/W2322203441","https://openalex.org/W2346424903"],"related_works":["https://openalex.org/W2557742543","https://openalex.org/W2591923295","https://openalex.org/W2907791145","https://openalex.org/W2551532204","https://openalex.org/W4400833148","https://openalex.org/W2264982566","https://openalex.org/W12411063","https://openalex.org/W2950600690","https://openalex.org/W2087854083","https://openalex.org/W4389246809"],"abstract_inverted_index":{"IMPORTANCE:":[0],"Therapy-related":[1],"myeloid":[2,41,101,199,367,407],"neoplasms":[3],"are":[4],"a":[5,91,116,167,216,332,352,363],"potentially":[6],"life-threatening":[7],"consequence":[8],"of":[9,25,63,69,86,95,169,194,198,209,211,226,335,337,398,406],"treatment":[10],"for":[11,39,127,280,366,385,395],"autoimmune":[12,188],"disease":[13],"(AID)":[14],"and":[15,28,51,161,166,178,311,342,371],"an":[16,60,219,340],"emerging":[17],"clinical":[18],"phenomenon.":[19],"OBJECTIVE:":[20],"To":[21],"query":[22],"the":[23,37,132,185,223,343,396,402],"association":[24,330,382,397],"cytotoxic,":[26],"anti-inflammatory,":[27],"immunomodulating":[29,220],"agents":[30,277],"to":[31,82,196,282,339],"treat":[32],"patients":[33,58,89,134],"with":[34,36,59,355,362,401],"AID":[35,71,195],"risk":[38,365],"developing":[40],"neoplasm.":[42,368,408],"DESIGN,":[43],"SETTING,":[44],"AND":[45,121,349],"PARTICIPANTS:":[46],"This":[47],"retrospective":[48],"case-control":[49,111],"study":[50],"medical":[52],"record":[53],"review":[54],"included":[55],"40":[56],"011":[57],"International":[61],"Classification":[62],"Diseases,":[64],"Ninth":[65],"Revision,":[66],"coded":[67,93],"diagnosis":[68,94,197],"primary":[70,356],"who":[72,135],"were":[73,184,324],"seen":[74],"at":[75,115],"2":[76],"centers":[77],"from":[78,192],"January":[79],"1,":[80],"2004,":[81],"December":[83],"31,":[84],"2014;":[85],"these,":[87],"311":[88],"had":[90,153,157,164,320,374],"concomitant":[92],"myelodysplastic":[96],"syndrome":[97],"(MDS)":[98],"or":[99,218],"acute":[100],"leukemia":[102],"(AML).":[103],"Eighty-six":[104],"cases":[105,213,257],"met":[106,136],"strict":[107],"inclusion":[108,137],"criteria.":[109],"A":[110,207],"match":[112],"was":[113,201,252,278,346,360,383,393],"performed":[114],"2:1":[117],"ratio.":[118],"MAIN":[119],"OUTCOMES":[120],"MEASURES:":[122],"Odds":[123],"ratio":[124,259],"(OR)":[125],"assessment":[126],"AID-directed":[128],"therapies.":[129],"RESULTS:":[130],"Among":[131],"86":[133,212],"criteria":[138],"(49":[139],"men":[140,230],"[57%];":[141],"37":[142],"women":[143,233],"[43%];":[144],"mean":[145,235],"[SD]":[146,236],"age,":[147,237],"72.3":[148],"[15.6]":[149],"years),":[150,240],"55":[151],"(64.0%)":[152],"MDS,":[154],"21":[155],"(24.4%)":[156],"de":[158],"novo":[159],"AML,":[160],"10":[162],"(11.6%)":[163],"AML":[165],"history":[168],"MDS.":[170],"Rheumatoid":[171],"arthritis":[172],"(23":[173],"[26.7%]),":[174],"psoriasis":[175],"(18":[176],"[20.9%]),":[177],"systemic":[179,376],"lupus":[180],"erythematosus":[181],"(12":[182],"[14.0%])":[183],"most":[186],"common":[187],"profiles.":[189],"Median":[190],"time":[191,336],"onset":[193],"neoplasm":[200],"8":[202],"(interquartile":[203],"range,":[204],"4-15)":[205],"years.":[206],"total":[208],"57":[210],"(66.3%)":[214],"received":[215,243],"cytotoxic":[217,276],"agent.":[221],"In":[222,351],"comparison":[224],"group":[225],"172":[227],"controls":[228],"(98":[229],"[57.0%];":[231],"74":[232],"[43.0%];":[234],"72.7":[238],"[13.8]":[239],"105":[241],"(61.0%)":[242],"either":[244],"agent":[245,341,379],"(P":[246],"=":[247],".50).":[248],"Azathioprine":[249],"sodium":[250,299],"use":[251,274],"observed":[253],"more":[254],"frequently":[255],"in":[256,404],"(odds":[258],"[OR],":[260],"7.05;":[261],"95%":[262,286,295,302,308,317],"CI,":[263,287,296,303,309,318],"2.35-":[264],"21.13;":[265],"P":[266],"<":[267],".001).":[268],"Notable":[269],"but":[270],"insignificant":[271],"case":[272,372],"cohort":[273],"among":[275],"found":[279,384,394],"exposure":[281,338,359,400],"cyclophosphamide":[283],"(OR,":[284,293,300,306,315],"3.58;":[285],"0.91-14.11)":[288],"followed":[289],"by":[290,378],"mitoxantrone":[291],"hydrochloride":[292,314],"2.73;":[294],"0.23-33.0).":[297],"Methotrexate":[298],"0.60;":[301],"0.29-1.22),":[304],"mercaptopurine":[305],"0.62;":[307],"0.15-2.53),":[310],"mycophenolate":[312],"mofetil":[313],"0.66;":[316],"0.21-2.03)":[319],"favorable":[321],"ORs":[322],"that":[323],"not":[325],"statistically":[326],"significant.":[327],"No":[328,381],"significant":[329],"between":[331],"specific":[333],"length":[334],"drug's":[344],"category":[345],"observed.":[347],"CONCLUSIONS":[348],"RELEVANCE:":[350],"large":[353],"population":[354],"AID,":[357],"azathioprine":[358],"associated":[361],"7-fold":[364],"The":[369],"control":[370],"cohorts":[373],"similar":[375],"exposures":[377],"category.":[380],"anti-tumor":[386],"necrosis":[387],"factor":[388],"agents.":[389],"Finally,":[390],"no":[391],"timeline":[392],"drug":[399],"incidence":[403],"development":[405]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":17},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":17},{"year":2019,"cited_by_count":17},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":10}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-02-10T00:00:00"}